Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort
Funding Information: This work and KTC were supported by grants from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) ( G069214 , G0B2317N , 1S38819N ). LC acknowledges FWO travel grant for a research visit at University of Oxford ( V431117N ). The authors thank the staff in Oxford in their support of the laboratory work and the donation of the probes used for enrichment of HCV. Publisher Copyright: © 2022 Elsevier B.V. ; Background: Although most currently used regimens for Hepatitis C virus (HCV) infections can be initiated without prior knowledge of genotype and subtype, genotypin... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Schlagwörter: | Antiviral resistance / Full genome / Hepatitis C virus / LiPA / Next-generation sequencing / Treatment failure / QR355 Virology / R Medicine / Virology / Infectious Diseases / Applied Microbiology and Biotechnology / SDG 3 - Good Health and Well-being / SDG 9 - Industry / Innovation / and Infrastructure |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26925908 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/10362/147814 |